Market closed · data as of 27 Aug 2026 · source NSE via Alphave. Open the live chart →
Dr. Agarwal's Health Care operates a chain of eye-care hospitals and clinics offering cataract, refractive and other eye surgeries, consultations, and sales of optical products, contact lenses and pharmaceuticals. The Chennai-headquartered network spans India across hub-and-spoke facilities along with a presence in Africa, and the company listed via IPO in early 2025. Revenue is driven by surgical volumes (particularly cataract) and optical retail attach.
India's largest eye-care services chain by network size.
Dr. Agarwal's Health Care Ltd. is a constituent of NIFTY MICROCAP 250. See where it sits on the market heatmap →
Consolidated annual figures taken from Dr. Agarwal's Health Care Ltd.'s own filed statements — not estimates, and not restated by us. The most recent period shown is FY26 (year ended 31 Mar 2026).
| Metric | FY26 | FY25 |
|---|---|---|
| EPS (basic, ₹) | 4.21 | 2.80 |
| Book value / share (₹) | 66.91 | 60.99 |
| Return on equity | 6.3% | 4.3% |
| Return on capital employed | 8.4% | 7.1% |
| Operating margin | 14.1% | 13.2% |
| Net margin | 8.1% | 6.5% |
| EBITDA | ₹570 Cr | ₹456 Cr |
| Free cash flow | ₹58 Cr | ₹39 Cr |
| Total debt | ₹157 Cr | ₹247 Cr |
| Debt to equity | 0.07 | 0.13 |
| Interest coverage | 3.2 | 2.1 |
| Current ratio | 1.24 | 1.66 |
| Shares outstanding | 31,68,00,000 | 31,59,00,000 |
Open the full income statement, balance sheet and cash flow for AGARWALEYE →
As disclosed for the quarter ended 30 Jun 2026.
Institutional ownership changes quarter to quarter. See daily FII and DII flows across the market →
Companies Alphave classifies in the same sub-sector, closest by market capitalisation.